Sotrovimab Biosimilar - Anti-SARS-CoV-2 Spike Protein RBD Antibody - BSA and Azide free, IgG1, Unconjugated, Human, Monoclonal
Artikelnummer:
ABC-A338905-100
| Artikelname: |
Sotrovimab Biosimilar - Anti-SARS-CoV-2 Spike Protein RBD Antibody - BSA and Azide free, IgG1, Unconjugated, Human, Monoclonal |
| Artikelnummer: |
ABC-A338905-100 |
| Hersteller Artikelnummer: |
A338905-100 |
| Alternativnummer: |
ABC-A338905-100 |
| Hersteller: |
Antibodies.com |
| Wirt: |
Human |
| Kategorie: |
Antikörper |
| Applikation: |
ELISA, FC |
| Spezies Reaktivität: |
Virus |
| Konjugation: |
Unconjugated |
| Recombinant human monoclonal antibody to SARS-CoV-2 Spike Protein RBD for use as a research grade Sotrovimab biosimilar. |
| Klonalität: |
Monoclonal |
| Isotyp: |
IgG1 |
| Puffer: |
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4. |
| Reinheit: |
The purity of this Biosimilar is >95%, as determined by SDS-PAGE. |
| Formulierung: |
Liquid |
| Target-Kategorie: |
SARS-CoV-2 Spike Protein RBD |
| Antibody Type: |
Primary Antibody |
